Nimotuzumab Significantly Enhances Chemosensitivity of
PC9 Human Lung Adenocarcinoma Cells to Paclitaxel in vitro

Nimotuzumab Significantly Enhances Chemosensitivity of
PC9 Human Lung Adenocarcinoma Cells to Paclitaxel in vitro

Background and objective Nimotuzumab is a humanized IgG1 type monoclonal antibody targeting epidermal growth factor receptor, and can enhance chemosensitivity and radiosensitivity of certain cancers. The aim of this study is to investigate the effects of nimotuzumab on the chemosensitivities of PC9...

Full description

Bibliographic Details
Main Authors: Yu XIAO, Baoshan CAO, Li LIANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Nimotuzumab
Paclitaxel
Lung neoplasms
PC9
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.02.09

Similar Items

Similar Items